Skip to main content
PMHS
OTC Life Sciences

Polomar Health's $750K Distribution Pact Terminated Amid Fraud Allegations

feedReported by Wiseek News
Sentiment info
Negative
Importance info
9
Price
$0.12
Mkt Cap
$3.366M
52W Low
$0.065
52W High
$960,000
Market data snapshot near publication time

summarizeSummary

Polomar Health Services (PMHS) has received notice from ForHumanity to terminate their Product Fulfillment and Distribution Agreement, which included a $750,000 guaranteed payment to Polomar, with $500,000 already disbursed. ForHumanity alleges fraudulent misrepresentation as the basis for termination, a claim Polomar disputes, asserting ForHumanity is in default. This event is highly material for PMHS, given its small market capitalization, as the loss of this distribution pact and the associated revenue stream could significantly impact its financial outlook. Furthermore, the allegations of fraud introduce substantial legal and reputational risks. Traders should monitor the progression of this dispute and any potential legal actions, as the outcome could have a profound effect on the company's valuation and operational viability.

At the time of this announcement, PMHS was trading at $0.12 on OTC in the Life Sciences sector, with a market capitalization of approximately $3.4M. The 52-week trading range was $0.07 to $960,000.00. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


show_chartPrice Chart

Share this article

Copied!

feed PMHS - Latest Insights

PMHS
Apr 29, 2026, 5:23 PM EDT
Source: Wiseek News
Importance Score:
9
PMHS
Apr 29, 2026, 5:17 PM EDT
Filing Type: 8-K
Importance Score:
9
PMHS
Mar 12, 2026, 4:50 PM EDT
Filing Type: DEFM14C
Importance Score:
9
PMHS
Feb 17, 2026, 4:35 PM EST
Filing Type: DEF 14C
Importance Score:
9
PMHS
Feb 05, 2026, 5:02 PM EST
Filing Type: PRE 14C
Importance Score:
9